Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·31 EkiNovo Nordisk kills oral insulin, rejigs R&D to address U.S. payers: ow.ly/kXi6305Hp2D $NVO @StacyALawrenceÇevir English0650
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·21 EkiEx-Moderna CSO resurfaces at PureTech after abrupt departure: ow.ly/rPZq305opEs @StacyALawrenceÇevir English1310
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·21 EkiRoche highlights I/O combos, as it drops solo development of vanucizumab: ow.ly/5pWL305opyK $RHHBY @StacyALawrenceÇevir English0310
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·20 EkiJ&J backs neuro startup BlackThorn in $40M Series A: ow.ly/EdDx305naj0 $JNJ @StacyALawrenceÇevir English0420
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·20 EkiSmall cap Rigel drops on PhIII failure for lead fostamatinib: ow.ly/q9s4305mVMb $RIGL @StacyALawrenceÇevir English0110
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·20 EkiNovartis invests, partners with Y Combinator grad in lysosomal storage disorders: ow.ly/PLMb305macq $NVS @StacyALawrenceÇevir English0660
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·19 EkiCelgene partners to develop ResearchKit app for observational study: ow.ly/47qB305k03D $AAPL $CELG @StacyALawrenceÇevir English0310
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·19 EkiJ&J eyes immuno-oncology with 15 R&D assets: ow.ly/jBPu305jZZs @StacyALawrence $JNJÇevir English0920
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·18 EkiAstraZeneca backs ADC in $105M to support 6 clinical oncology candidates: ow.ly/SRTQ305irjN $AZN @StacyALawrenceÇevir English0310
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·18 EkiMedicines Co. up on expectations of a twice-yearly anti-PCSK9: ow.ly/TDJS305iaIr $MDCO @StacyALawrenceÇevir English0220
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·7 EkiClovis reveals ovarian cancer data underlying upcoming FDA review: ow.ly/42tc304X98F $CLVS @StacyALawrenceÇevir English0420
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·6 EkiMerck, NewLink nab up to $76M BARDA contract to back Ebola vaccine: ow.ly/LuH7304UjSO $MRK $NLNK @StacyALawrenceÇevir English0130
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·3 EkiA pair of biotech IPOs line up: Myovant and Ra Pharma: ow.ly/Pv5o304NI47 by @StacyALawrenceÇevir English0210
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·3 EkiFidelity backs rare disease startup with $48M to get pivotal data: ow.ly/8KFQ304NyaC via @StacyALawrenceÇevir English0730
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·23 EylMicrocap BioLineRx in-licenses a second NASH candidate under Novartis deal - fiercebiotech.com/biotech/micro-…Çevir English0110
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·23 EylIntrexon partners with a pair of its fund portfolio startups - fiercebiotech.com/biotech/intrex…Çevir English0440
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·22 EylGerman next-gen checkpoint inhibitor startup reels in €40M: ow.ly/niRy304rTNw @StacyALawrenceÇevir English0640
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·22 EylInvestors go bargain shopping as Novan IPO prices low, climbs high: ow.ly/TWRG304rOsL @StacyALawrenceÇevir English0220
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·21 EylModerna to plough $110M into manufacturing build-out: ow.ly/FZxU304pZeV @StacyALawrenceÇevir English0520
Stacy Lawrence retweetlediFierceBiotech@FierceBiotech·20 EylJ&J builds on Geron partnership despite ongoing setbacks: ow.ly/8i2N304nVRk $JNJ $GERN @StacyALawrenceÇevir English1310